Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
DOCS

DOCS - Doximity, Inc. Stock Price, Fair Value and News

28.03USD+4.29 (+18.07%)Market Closed

Market Summary

DOCS
USD28.03+4.29
Market Closed
18.07%

DOCS Stock Price

View Fullscreen

DOCS RSI Chart

DOCS Valuation

Market Cap

5.2B

Price/Earnings (Trailing)

37.92

Price/Sales (Trailing)

11.14

EV/EBITDA

27.63

Price/Free Cashflow

31.32

DOCS Price/Sales (Trailing)

DOCS Profitability

Operating Margin

88.94%

EBT Margin

37.15%

Return on Equity

15.92%

Return on Assets

13.75%

Free Cashflow Yield

3.19%

DOCS Fundamentals

DOCS Revenue

Revenue (TTM)

468.3M

Rev. Growth (Yr)

17.37%

Rev. Growth (Qtr)

19.08%

DOCS Earnings

Earnings (TTM)

137.6M

Earnings Growth (Yr)

43.29%

Earnings Growth (Qtr)

56.71%

Breaking Down DOCS Revenue

Last 7 days

19.9%

Last 30 days

11.3%

Last 90 days

-7.6%

Trailing 12 Months

-15.8%

How does DOCS drawdown profile look like?

DOCS Financial Health

Current Ratio

8.03

DOCS Investor Care

Buy Backs (1Y)

3.52%

Diluted EPS (TTM)

0.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023419.1M436.9M448.3M468.3M
2022343.5M361.5M384.4M401.7M
2021206.9M243.2M277.4M316.6M
2020116.4M139.0M161.6M184.3M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Doximity, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
wampler kira scherer
acquired
-
-
2,500
-
Apr 01, 2024
wampler kira scherer
sold
-67,425
26.97
-2,500
-
Mar 01, 2024
wampler kira scherer
sold
-69,700
27.88
-2,500
-
Mar 01, 2024
wampler kira scherer
acquired
-
-
2,500
-
Feb 21, 2024
emergence capital partners ii lp
sold
-
-
-1,928,000
-
Feb 21, 2024
emergence capital partners ii lp
acquired
-
-
1,928,000
-
Feb 21, 2024
spain kevin
sold
-
-
-1,928,000
-
Feb 21, 2024
spain kevin
acquired
-
-
1,928,000
-
Feb 16, 2024
overpeck craig
sold
-45,030
30.02
-1,500
see remarks
Feb 15, 2024
bryson anna
acquired
-
-
104,091
chief financial officer

1–10 of 50

Which funds bought or sold DOCS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
Pineridge Advisors LLC
sold off
-100
-1,150
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-9.6
-452,435
2,963,030
-%
May 16, 2024
Grandeur Peak Global Advisors, LLC
reduced
-78.31
-3,036,170
797,962
0.06%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-60.55
-2,246,130
1,368,590
-%
May 16, 2024
COMERICA BANK
added
4.05
-2,444
1,714,290
0.01%
May 15, 2024
Alberta Investment Management Corp
reduced
-14.61
-154,102
699,660
0.01%
May 15, 2024
ALGERT GLOBAL LLC
reduced
-7.39
-113,000
901,000
0.04%
May 15, 2024
Voya Investment Management LLC
reduced
-4.32
-329,504
3,700,820
-%
May 15, 2024
Royal Bank of Canada
reduced
-26.64
-740,000
1,756,000
-%
May 15, 2024
D. E. Shaw & Co., Inc.
sold off
-100
-3,144,860
-
-%

1–10 of 38

Are Funds Buying or Selling DOCS?

Are funds buying DOCS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own DOCS
No. of Funds

Unveiling Doximity, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
tangney jeffrey
31.5%
54,958,180
SC 13G/A
Feb 14, 2024
emergence capital partners ii lp
10.9%
14,462,728
SC 13G/A
Feb 13, 2024
vanguard group inc
9.23%
10,900,648
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Feb 09, 2024
clearbridge investments, llc
5.0%
5,922,010
SC 13G/A
Feb 08, 2024
morgan stanley
5.7%
6,749,692
SC 13G/A
Jan 30, 2024
baillie gifford & co
5.33%
6,299,503
SC 13G
Jan 25, 2024
blackrock inc.
8.9%
10,540,334
SC 13G
Sep 08, 2023
morgan stanley
7.6%
9,556,526
SC 13G/A
Mar 08, 2023
blackrock inc.
4.5%
5,381,384
SC 13G/A

Recent SEC filings of Doximity, Inc.

View All Filings
Date Filed Form Type Document
May 17, 2024
144
Notice of Insider Sale Intent
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 16, 2024
8-K
Current Report
Apr 02, 2024
4
Insider Trading
Apr 01, 2024
144
Notice of Insider Sale Intent
Mar 04, 2024
4
Insider Trading
Mar 01, 2024
144
Notice of Insider Sale Intent
Feb 23, 2024
4
Insider Trading

Peers (Alternatives to Doximity, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
482.9B
379.5B
9.53% 9.48%
31.44
1.27
12.96% -25.81%
96.2B
206.0B
-2.11% 32.08%
24.97
0.47
12.55% -43.95%
84.6B
66.7B
3.80% 15.55%
15.46
1.27
9.59% -4.59%
72.4B
360.9B
-15.92% -16.78%
9.89
0.2
9.07% 78.49%
41.7B
155.5B
8.44% 18.66%
15.24
0.27
6.34% 84.42%
12.3B
12.3B
9.53% 38.52%
15.03
0.99
5.77% 58.74%
11.9B
14.7B
11.04% 30.82%
14.63
0.81
7.99% 19.23%
MID-CAP
8.5B
2.3B
-6.47% 5.37%
30.15
3.73
5.96% 18.29%
6.2B
3.0B
-5.49% -7.73%
-545.12
2.06
10.92% -104.06%
2.3B
1.5B
9.06% 20.53%
36.62
1.57
19.34% 40.15%
2.2B
3.5B
4.01% -38.44%
15.49
0.64
-27.67% -62.43%
SMALL-CAP
1.8B
1.1B
14.53% 25.72%
27.59
1.67
11.45% 30.74%
1.3B
3.0B
6.97% 85.25%
-7.66
0.44
4.98% 4.88%
54.5M
-
-4.17% -6.33%
-3.61
-
- -1.05%
22.0M
21.6M
16.05% 23.93%
39.79
1.02
9.04% -50.63%

Doximity, Inc. News

Latest updates
Defense World2 hours ago
Yahoo Finance41 hours ago

Doximity, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Revenue19.1%13511410811111510291.0094.0098.0079.0073.0067.0059.0045.0036.00-
Cost Of Revenue-4.5%12.0013.0013.0014.0014.0013.0013.0012.0011.009.008.008.008.007.008.00-
Gross Profit22.1%12310195.0097.0010289.0078.0082.0087.0070.0065.0059.0051.0038.0029.00-
Operating Expenses-3.8%65.0067.0066.0064.0063.0057.0056.0054.0051.0045.0040.0036.0033.0027.0026.00-
  S&GA Expenses15.7%35.0030.0034.0033.0033.0029.0028.0026.0026.0021.0019.0018.0017.0014.0013.00-
  R&D Expenses-0.1%20.0020.0022.0022.0021.0019.0019.0017.0016.0015.0013.0013.0011.0010.0010.00-
EBITDA Margin8.7%0.39*0.36*0.36*0.34*0.33*0.33*0.33*0.35*0.36*0.36*0.35*0.30*0.13*0.15*0.18*0.21*
Income Taxes65.8%15.009.006.006.007.007.000.00-8.82-19.84-10.72-1.401.005.000.000.00-
Earnings Before Taxes58.8%63.0040.0035.0037.0041.0033.0022.0028.0036.0025.0025.0023.0023.0010.002.00-
EBT Margin9.6%0.37*0.34*0.33*0.32*0.31*0.31*0.31*0.33*0.34*0.35*0.33*0.28*0.13*0.15*0.17*0.20*
Net Income56.7%48.0031.0028.0031.0033.0026.0022.0037.0056.0036.0026.0021.0017.0010.001.00-
Net Income Margin7.0%0.29*0.27*0.27*0.27*0.30*0.37*0.42*0.45*0.44*0.36*0.31*0.24*0.16*0.18*0.21*0.26*
Free Cashflow289.0%50.0013.0057.0047.0048.0039.0044.0046.0027.0019.0033.0037.0024.0013.009.00-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q1
Assets-2.4%1,0011,0261,1541,1371,0671,0281,051991932869830252
  Current Assets-2.5%841863990975899848874904858830791209
    Cash Equivalents13.5%12310830715813674.0011011385.0080.0059466.00
  Net PPE0.5%12.0012.0012.0011.0012.0012.0011.008.008.008.008.008.00
  Goodwill0%68.0068.0068.0068.0068.0068.0068.0049.0019.0019.0019.0019.00
Liabilities-11.7%13615416317113714914911393.0097.00102104
  Current Liabilities-15.0%10512313314010611812111192.0096.00100102
Shareholder's Equity-0.8%86587199196693087990287983977372867.00
  Retained Earnings-28.6%61.0085.0022521820317020519115499.0063.0036.00
  Additional Paid-In Capital1.7%80879577876274673171570368867466630.00
Shares Outstanding-1.2%18618919519419319319319215418688.0074.00
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Cashflow From Operations288.1%50,05412,89857,20046,63948,69739,51444,75246,96427,28419,15233,17537,55123,96112,7018,760-
  Share Based Compensation-12.5%11,77113,44714,00112,99113,98411,3539,5069,8099,8346,6725,1272,8702,2201,179983-
Cashflow From Investing180.1%40,132-50,102117,326-13,20413,304-18,523-41,500-23,626-25,520-534,005-57,423-42,869-27,26714,529-14,810-
Cashflow From Financing53.1%-75,500-161,122-25,824-11,862779-57,409-5,9694,3923,79453.00552,1761,7362,3241,124223-
  Buy Backs-95.3%8,000170,36321,75515,28221.0061,1688,874---2,6981,652370---
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

DOCS Income Statement

2023-12-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue$ 135,284$ 115,262$ 357,365$ 308,086
Cost of revenue12,19013,52638,10239,813
Gross profit123,094101,736319,263268,273
Operating expenses:    
Research and development19,94620,51961,83558,645
Sales and marketing34,95633,22099,61290,375
General and administrative9,6419,51327,85426,986
Restructuring007,9360
Total operating expenses64,54363,252197,237176,006
Income from operations58,55138,484122,02692,267
Other income, net4,4812,46115,2234,173
Income before income taxes63,03240,945137,24996,440
Provision for income taxes15,0767,47730,28514,290
Net income$ 47,956$ 33,468$ 106,964$ 82,150
Net income per share attributable to Class A and Class B common stockholders:    
Basic (in dollars per share)$ 0.26$ 0.17$ 0.56$ 0.43
Diluted (in dollars per share)$ 0.24$ 0.16$ 0.52$ 0.38
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:    
Basic (in shares)186,309192,805191,302192,963
Diluted (in shares)200,463212,065207,265213,656

DOCS Balance Sheet

2023-12-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Current assets:  
Cash and cash equivalents$ 123,089$ 158,027
Marketable securities587,149682,972
Accounts receivable, net of allowance for doubtful accounts of $1,714 and $887 at December 31, 2023 and March 31, 2023, respectively97,584107,047
Prepaid expenses and other current assets27,19122,289
Deferred contract costs, current5,8865,118
Total current assets840,899975,453
Property and equipment, net11,83911,279
Deferred income tax assets37,20434,907
Operating lease right-of-use assets12,80813,819
Intangible assets, net28,37931,836
Goodwill67,94067,940
Other assets1,5801,654
Total assets1,000,6491,136,888
Current liabilities:  
Accounts payable1,8801,272
Accrued expenses and other current liabilities34,07931,245
Deferred revenue, current66,694105,238
Operating lease liabilities, current2,1091,752
Total current liabilities104,762139,507
Deferred revenue, non-current166198
Operating lease liabilities, non-current12,94713,885
Contingent earn-out consideration liability, non-current10,78715,942
Income taxes payable, non-current6,53299
Other liabilities, non-current8411,141
Total liabilities136,035170,772
Commitments and contingencies (Note 13)
Stockholders' Equity  
Preferred stock, $0.001 par value; 100,000 shares authorized as of December 31, 2023 and March 31, 2023, respectively; zero shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively00
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of December 31, 2023 and March 31, 2023, respectively; 186,175 and 193,941 shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively186194
Additional paid-in capital808,078762,150
Accumulated other comprehensive loss(4,653)(14,083)
Retained earnings61,003217,855
Total stockholders’ equity864,614966,116
Total liabilities and stockholders’ equity$ 1,000,649$ 1,136,888
DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
 CEO
 WEBSITEdoximity.com
 INDUSTRYHealthcare Plans
 EMPLOYEES900

Doximity, Inc. Frequently Asked Questions


What is the ticker symbol for Doximity, Inc.? What does DOCS stand for in stocks?

DOCS is the stock ticker symbol of Doximity, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Doximity, Inc. (DOCS)?

As of Fri May 17 2024, market cap of Doximity, Inc. is 5.22 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DOCS stock?

You can check DOCS's fair value in chart for subscribers.

What is the fair value of DOCS stock?

You can check DOCS's fair value in chart for subscribers. The fair value of Doximity, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Doximity, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DOCS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Doximity, Inc. a good stock to buy?

The fair value guage provides a quick view whether DOCS is over valued or under valued. Whether Doximity, Inc. is cheap or expensive depends on the assumptions which impact Doximity, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DOCS.

What is Doximity, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, DOCS's PE ratio (Price to Earnings) is 37.92 and Price to Sales (PS) ratio is 11.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DOCS PE ratio will change depending on the future growth rate expectations of investors.